Patents by Inventor Chenliang Guo

Chenliang Guo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11419801
    Abstract: The invention relates to a personal care composition, more particularly to a composition for application to a topical surface that prevents or reduces inflammation. The composition could be delivered in the form of a skin, scalp, hair or oral care product, more particularly a skin care product. The benefit is delivered via a combination of a polyunsaturated fatty acid (PUFA) or ester thereof selected from docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), DHA-ethyl ester, EPA-ethyl ester, DHA-triglyceride, EPA-triglyceride, dihomogamma-Linolenic Acid (DGLA), DGLA-ethyl ester, DGLA-triglyceride or combinations thereof and a 4-substituted resorcinol compound, wherein the mole ratio of the PUFA or ester thereof to the 4-substituted resorcinol compound is 5:1 to 1:5.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: August 23, 2022
    Assignee: CONOPCO, INC.
    Inventors: Chenliang Guo, Nan Huang, Sheila Alves Rocha
  • Publication number: 20200360252
    Abstract: The invention relates to a personal care composition, more particularly to a composition for application to a topical surface that prevents or reduces inflammation. The composition could be delivered in the form of a skin, scalp, hair or oral care product, more particularly a skin care product. The benefit is delivered via a combination of a polyunsaturated fatty acid (PUFA) or ester thereof selected from docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), DHA-ethyl ester, EPA-ethyl ester, DHA-triglyceride, EPA-triglyceride, dihomogamma-Linolenic Acid (DGLA), DGLA-ethyl ester, DGLA-triglyceride or combinations thereof and a 4-substituted resorcinol compound, wherein the mole ratio of the PUFA or ester thereof to the 4-substituted resorcinol compound is 5:1 to 1:5.
    Type: Application
    Filed: August 17, 2018
    Publication date: November 19, 2020
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Chenliang GUO, Nan HUANG, Sheila Alves ROCHA
  • Publication number: 20200206173
    Abstract: The invention relates to a personal care composition, more particularly to a composition for use to reduce or prevent inflammation on a topical surface of a human or animal body. The composition could be delivered in the form of a skin, scalp, hair or oral care product, more particularly a skin care product. The benefit is delivered via a combination of a polyunsaturated fatty acid (PUFA) or an ester thereof and a vitamin B3 compound wherein the mole ratio of the PUFA or ester thereof to the vitamin B3 compound is 1:15 to 1:500.
    Type: Application
    Filed: August 17, 2018
    Publication date: July 2, 2020
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Chenliang Guo, Nan HUANG, Sheila Alves ROCHA